Mohammad Reza Zafarghandi
Following the success of Iranian scientists in using stem cells to treat vascular occlusion and critical limb ischemia in the lower extremities, Press TV has conducted an interview with research team leader Mohammad Reza Zafarghandi.
Dr. Zafarghandi is a professor of vascular surgery in Tehran University of medical Sciences and the head of the vascular surgery and trauma department of Sina Hospital.
Press TV: According to news reports, you have successfully treated 12 patients suffering from vascular occlusion using stem cells. Could you tell us more about it?
Zafarghandi: Critical limb ischemia (CLI) results from severe occlusive disease that
Bioheart Inc, a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announces an update on the phase I safety trial using adipose derived cells.
Approximately four years ago in April, 2010, Bioheart initiated a study using adipose derived stem cells (AdipoCell(TM)) in congestive heart failure patients. In collaboration with the Regenerative Medicine Institute of Tijuana, Mexico, five congestive heart failure patients were successfully treated in the initial pilot trial at Hospital Angeles Tijuana. Patients underwent a mini-lipoaspiration procedure where 60ccs of fat were removed.
This fat was processed to obtain the stromal vascular fraction (SVF) which